✦ LIBER ✦

Public Sensationalism and Clinical Trials: How to Address the Challenges of Science?

✍ Scribed by E. Magnus Ohman; Matthew T. Roe; Paul W. Armstrong; Keith A. Fox; Dorairaj Prabhakaran; Harvey D. White

Book ID: 116212657
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 119 KB
Volume: 123
Category: Article
ISSN: 1555-7162
DOI: 10.1016/j.amjmed.2009.12.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decision-making and breast cancer clinic

Decision-making and breast cancer clinical trials: How experience challenges attitudes

✍ Julien Mancini; Jean Genève; Florence Dalenc; Dominique Genre; Alain Monnier; Pi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Addressing Challenges to Public Understa

Addressing Challenges to Public Understanding of Science: Epistemic Cognition, Motivated Reasoning, and Conceptual Change

✍ Sinatra, Gale M.; Kienhues, Dorothe; Hofer, Barbara K. 📂 Article 📅 2014 🏛 Taylor and Francis Group 🌐 English ⚖ 183 KB

SP029 Keynote address: Overcoming the ch

SP029 Keynote address: Overcoming the challenges of biospecimen collection for R&D, clinical trials and biobanking

✍ Thomas, G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB

How to connect the gap between clinical

How to connect the gap between clinical trials and clinical practice

✍ Hong-cai Shang; Hong-juan Xu; Jing Chen; Bo-li Zhang; You-ping Li; Mike J. Clark 📂 Article 📅 2008 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 76 KB 👁 1 views

The evolution of legislation to regulate

The evolution of legislation to regulate pediatric clinical trials: Present and continuing challenges

✍ Kathleen R. Gans-Brangs; Paul V. Plourde 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Challenges in the recruitment of adolesc

Challenges in the recruitment of adolescents and young adults to cancer clinical trials

✍ Megan E. Burke; Karen Albritton; Neyssa Marina 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 3 views

## Abstract The adolescent and young adult (AYA) oncology population has seen inferior progress in cancer survival compared with younger children and older adults over the past 25 years. Previously, AYAs had the best survival rates due to the prevalence of highly curable diseases including Hodgkin